Shaolin Capital Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-359,721
Closed -$3.69M – 919
2023
Q2
$3.69M Sell
359,721
-12,915
-3% -$132K 0.12% 124
2023
Q1
$3.77M Sell
372,636
-2,364
-0.6% -$23.8K 0.11% 165
2022
Q4
$3.75M Buy
375,000
+150,000
+67% +$1.48M 0.11% 237
2022
Q3
$2.19M Hold
225,000
– – 0.06% 348
2022
Q2
$2.18M Buy
225,000
+47,223
+27% +$459K 0.05% 389
2022
Q1
$1.73M Buy
+177,777
New +$1.72M 0.04% 424

Shaolin Capital Management's DALS Position: Q3 2023 in Review

Shaolin Capital Management sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 359,721 shares — an estimated $3.69M sold.

Shaolin Capital Management first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $3.77M in Q1 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Shaolin Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Shaolin Capital Management sold 359,721 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $3.69M.
  • Shaolin Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q1 2022 and held it in 6 quarters.
  • Shaolin Capital Management's DA32 Life Science Tech Acquisition Corp position peaked at $3.77M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Shaolin Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.